These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14686689)

  • 21. Preventing diabetes, Part II: an action plan.
    Harv Mens Health Watch; 2007 Jul; 11(12):4-6. PubMed ID: 17687795
    [No Abstract]   [Full Text] [Related]  

  • 22. Acarbose for polycystic ovary syndrome.
    Kircher C; Smith KP
    Ann Pharmacother; 2008 Jun; 42(6):847-51. PubMed ID: 18460589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for diabetes.
    Abramowicz M; Zuccotti G;
    Treat Guidel Med Lett; 2005 Aug; 3(36):57-62. PubMed ID: 16012392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Is it possible to prevent type 2 diabetes?].
    Laville M
    Ann Endocrinol (Paris); 2003 Jun; 64(3 Suppl):S37-44. PubMed ID: 12910058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin: Mechanisms in Human Obesity and Weight Loss.
    Yerevanian A; Soukas AA
    Curr Obes Rep; 2019 Jun; 8(2):156-164. PubMed ID: 30874963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing type 2 diabetes. A look at the newer agents.
    Larmore SS
    JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary prevention of type 2 diabetes: how do we do it?
    Abdul-Ghani MA; Sabah M; Minuchin O; Vardi P; Raz I; Wainstein J
    Isr Med Assoc J; 2004 May; 6(5):305-7. PubMed ID: 15151376
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic prevention or delay of type 2 diabetes mellitus.
    Anderson DC
    Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic treatment options for prediabetes.
    Hsueh WA; Handelsman Y
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):380-1. PubMed ID: 18523427
    [No Abstract]   [Full Text] [Related]  

  • 31. Weight beneficial treatments for type 2 diabetes.
    Meneghini LF; Orozco-Beltran D; Khunti K; Caputo S; Damçi T; Liebl A; Ross SA
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3337-53. PubMed ID: 21900381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin use in adolescents.
    Gray L; Lee JH; Nashelsky J
    Am Fam Physician; 2013 Apr; 87(8):od4. PubMed ID: 23668452
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review.
    Lentferink YE; Knibbe CAJ; van der Vorst MMJ
    Drugs; 2018 Dec; 78(18):1887-1901. PubMed ID: 30511324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin therapy for diabetes in Prader-Willi syndrome.
    Chan NN; Feher MD; Bridges NA
    J R Soc Med; 1998 Nov; 91(11):598. PubMed ID: 10325882
    [No Abstract]   [Full Text] [Related]  

  • 35. Diet and exercise. Preventing diabetes.
    Harv Health Lett; 2002 May; 27(7):6. PubMed ID: 12034555
    [No Abstract]   [Full Text] [Related]  

  • 36. Metformin: a useful adjunct to insulin therapy?
    Bailey CJ
    Diabet Med; 2000 Jan; 17(1):83-4. PubMed ID: 10691167
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J; Soszyński P
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of metformin as an adjunct to hydroxycitrate/carnitine for reducing body fat in diabetics.
    McCarty MF
    Med Hypotheses; 1998 Nov; 51(5):399-403. PubMed ID: 9848468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acarbose: oral anti-diabetes drug with additional cardiovascular benefits.
    Hanefeld M; Schaper F
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):153-63. PubMed ID: 18248270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acarbose for type 2 diabetes prevention.
    Mühlhauser I
    Lancet; 2002 Nov; 360(9344):1517; author reply 1517. PubMed ID: 12433559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.